Cargando…

Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL)

Introduction: While the approval of three commercial vaccines for the SARS-CoV-2 virus has provided upwards of 95% protection against the coronavirus for healthy subjects, the efficacy among patients with hematologic malignancies remains unknown. Immune dysfunction and impaired humoral responses to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayers, Emily C., Wilson, Jeffrey, Canderan, Glenda, Keshavarz, Behnam, Woodfolk, Judith, Portell, Craig A., Williams, Michael E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701483/
http://dx.doi.org/10.1182/blood-2021-146165